SCHEMBL7369721

SCHEMBL7369721

C=CCc1cccc(C(=O)O)c1C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 1/20 0.45
GABRA1 P14867 1/20 0.44
GABRB2 P47870 1/20 0.44
TSHR P16473 2/20 0.44
FOLH1 Q04609 1/20 0.43
ALDH1A1 P00352 5/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 4/20 0.42
HPGD P15428 2/20 0.42
CLCN2 P51788 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HMGB1 P09429 1/20 0.40
KMT2A Q03164 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1137942 0.84 GABRA1 (0.46) GABRA1GABRB2TSHRFOLH1ALDH1A1
SCHEMBL2731264 0.84 MRGPRX4 (0.46) MRGPRX4TSHRFOLH1ALDH1A1POLB
SCHEMBL89060 0.83 FOLH1 (0.55) GABRA1GABRB2TSHRFOLH1ALDH1A1
Benzene SCHEMBL27083018 0.83 FOLH1 (0.55) GABRA1GABRB2TSHRFOLH1ALDH1A1
Ammonia Solution, Strong SCHEMBL16531812 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1
Phosphine SCHEMBL28264956 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1
SCHEMBL11094883 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1
Hydrochloric Acid SCHEMBL7974299 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1
Potassium SCHEMBL16531822 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1
Ammonia Solution, Strong SCHEMBL9940062 0.82 FOLH1 (0.53) GABRA1GABRB2TSHRFOLH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114409538-A Allyl benzoate compound and preparation method thereof 湖北工业大学 2022-04-29 CN claimed
EP-0695184-B1 HIV PROTEASE INHIBITORS AGOURON PHARMA (US) 1999-04-21 EP disclosed
US-5863950-A AMIDES OR THIO AMIDE COMPOUNDS WITH HYDROXY OR ETHER GROUPS AGOURON PHARMACEUTICALS, INC. (US) 1999-01-26 US disclosed
US-5714518-A HIV protease inhibitors and methods of making the same AGOURON PHARMACEUTICALS (US) 1998-02-03 US disclosed
EP-0695184-A4 HIV PROTEASE INHIBITORS AGOURON PHARMA (US) 1996-05-22 EP disclosed
EP-0695184-A1 HIV PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1996-02-07 EP disclosed
WO-1994015906-A1 HIV PROTEASE INHIBITORS AND THEIR PREPARATION AGOURON PHARMACEUTICALS, INC. (US) 1994-07-21 WO disclosed
WO-1994015608-A1 HIV PROTEASE INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 1994-07-21 WO disclosed